Somerville, MA, United States of America

Andre Lescarbeau

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 6.3

ph-index = 14

Forward Citations = 452(Granted Patents)


Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Andre Lescarbeau: A Pioneer in Kinase Modulation**

Introduction

Andre Lescarbeau, based in Somerville, MA, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 31 patents. His innovative work primarily focuses on compounds that modulate kinase activity, shedding light on their potential uses in treating various diseases.

Latest Patents

Among his latest patents are "Heterocyclic Compounds and Uses Thereof" and "Solid Forms of Isoquinolinones, and Process of Making, Composition Comprising, and Methods of Using the Same." The first patent describes pharmaceutical compositions that can modulate kinase activity, particularly PI3 kinase, and provides methods for treating conditions linked to these pathways. The second patent discusses solid forms of chemical compounds and outlines processes to prepare and utilize these compounds effectively.

Career Highlights

Throughout his career, Andre Lescarbeau has worked with notable companies, including Infinity Pharmaceuticals, Inc. and Infinity Discovery, Inc. His experience in these innovative environments has enabled him to contribute to significant advancements in drug discovery and development.

Collaborations

Lescarbeau has collaborated with esteemed colleagues such as Martin R Tremblay and Alfredo C Castro. These partnerships have facilitated the exchange of ideas and propelled forward multiple research initiatives within the realm of kinase modulation.

Conclusion

Andre Lescarbeau is a remarkable inventor whose work continues to influence the pharmaceutical landscape. His extensive patent portfolio highlights his expertise and commitment to developing therapeutic solutions that target kinase activity, paving the way for advancements in the treatment of various conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…